Allison Brennan, MPP, discusses legislation that would affect accountable care organizations (ACOs), the impact coronavirus disease 2019 had on ACOs, and the fall National Association of ACOs meeting.
The move to value-based care has been a long process in the United States, perhaps made even longer by policies that some view as discouraging providers and health systems from participating in alternative payment models and now a pandemic that may stall the transition. As a result of coronavirus disease 2019 (COVID-19), CMS announced it would stop accepting applications for new accountable care organizations in 2021.
However, the National Association of ACOs (NAACOS) is still pushing forward. The organization is supporting new legislation in the House of Representatives that would update Medicare’s ACO program and reward participating ACOs.
Allison Brennan, MPP, senior vice president of government affairs at NAACOS, discusses the new Value in Health Care Act, how other policy changes at CMS have impacted ACOs, and the effect COVID-19 has had on ACOs.
Listen above or through one of these podcast services:
Learn more:
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
For Community Oncology, Good News in PFS Offset by Potential Wreckage of MFP Proposal
July 15th 2025CMS proposes the 2026 Physician Fee Schedule (PFS), addressing payment disparities in oncology, but the community oncology community warns of financial threats from the Inflation Reduction Act. Updates reflect late Tuesday release of the proposed 2026 schedule for the Hospital Outpatient Prospective Payment System.
Read More
The Future of Drug Pricing: Most Favored Nation, PBMs, and Patient Access
July 11th 2025During the Reshaping Rx: Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at pharmacy benefit managers (PBMs), and other drug pricing policies.
Read More